Blood biomarkers predict risk in children's heart disease. Around 1,000 children in the UK have a heart condition called hypertrophic cardiomyopathy (HCM)that thickens their heart muscle. It’s rare, but it can be dangerous and even cause sudden death.
New research shows that a simple blood test can identify this condition and even predict higher-risk cases. This test might help diagnose and treat children with HCM faster. According to Professor Juan Pablo Kaski from the UCL Institute of Cardiovascular Science and Great Ormond Street Hospital, a new blood test called HCM could be a game-changer for kids with a heart problem.
This problem can be dangerous and even cause sudden death. The current tests are expensive and not always available, causing parents stress and uncertainty. However, this new blood test could be quicker, more accessible, and affordable, potentially relieving some of the burden and helping doctors find and treat kids with HCM faster.
Researchers at UCL are not just working in their respective fields; they are part of a multidisciplinary dream team. These experts from biology, computers, and other fields are collaborating to use super-smart tools like Artificial Intelligence (AI) to develop brand-new tests, like the blood test for heart problems. This innovative approach is the future of medical diagnosis, and UCL is at the forefront of this exciting research, instilling confidence in medical science’s potential to revolutionize healthcare.
A brave 7-yea.
